Ledger.Open graph →
SEC Form D · filed November 25, 2014

Sanguine BioSciences, Inc

Offering
$7.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SHERMAN OAKS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Tim Triche · Sherman Oaks, CADirectorRandy Socol · San Diego, CAExecJuliana Obregon · Newark, DEExecRudiger Hausherr · Sherman Oaks, CADirectorBrian Neman · Sherman Oaks, CAExec · DirectorJoseph Schocken · Seattle, WAExecTim Triche · Sherman Oaks, CADirectorRudiger Hausherr · Sherman Oaks, CADirectorBrian Neman · Sherman Oaks, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗